• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Spectr . Prior immunity to seasonal influenza A(H3N2) virus confers varying levels of cross-protection against challenge with clade 2.3.4.

tetano

Editor, Senior Moderator
Microbiol Spectr


. 2026 Apr 30:e0397425.
doi: 10.1128/spectrum.03974-25. Online ahead of print.
Prior immunity to seasonal influenza A(H3N2) virus confers varying levels of cross-protection against challenge with clade 2.3.4.4b A(H5N1), A(H7N9), or A(H9N2) virus in a ferret model

Xiangjie Sun[SUP] 1 [/SUP], Jessica A Belser[SUP] 1 [/SUP], Zhu-Nan Li[SUP] 1 [/SUP], Feng Liu[SUP] 1 [/SUP], Nicole Brock[SUP] 1 [/SUP], Joanna A Pulit-Penaloza[SUP] 1 [/SUP], Troy J Kieran[SUP] 1 [/SUP], Claudia Pappas[SUP] 1 [/SUP], Hui Zeng[SUP] 1 [/SUP], Jessie C Chang[SUP] 1 [/SUP], Paul J Carney[SUP] 1 [/SUP], Brandon L Bradley-Ferrell[SUP] 1 [/SUP], James Stevens[SUP] 1 [/SUP], Min Z Levine[SUP] 1 [/SUP], Terrence M Tumpey[SUP] 1 [/SUP], Taronna R Maines[SUP] 1 [/SUP]


Affiliations
Free article Abstract

Evaluating how prior immunity to seasonal influenza viruses influences subsequent zoonotic influenza A virus (IAV) infection in animal models is critical for pandemic preparedness. In this study, we investigated the cross-protective effect of pre-existing A(H3N2) immunity in ferrets challenged with three distinct subtypes of zoonotic IAVs: low pathogenic A(H7N9) and A(H9N2) viruses, and highly pathogenic clade 2.3.4.4b A(H5N1) virus. Our results show that A(H3N2) preimmunity conferred some protection against A(H5N1) and A(H9N2) virus infection, as evidenced by more rapid viral clearance in the upper respiratory tract, reduced virus shedding in the nasal wash on select days post-inoculation, and a lowered frequency of viral detection in specific tissues compared with naive animals. In contrast, A(H3N2) preimmunity provided minimal cross-protection against A(H7N9) infection, as weight loss and viral dissemination in tissues were not significantly reduced in A(H3N2) preimmune ferrets relative to naive animals. These findings highlight the variable breadth and magnitude of cross-protection elicited by prior seasonal IAV immunity against zoonotic influenza virus challenges in the ferret model. Seasonal influenza A(H3N2) preimmunity provided differing levels of cross-protection against zoonotic influenza A virus infections in ferrets.
Importance: Understanding how pre-existing influenza immunity shapes susceptibility to zoonotic IAV infections is essential for risk assessment and pandemic preparedness. By evaluating the extent and magnitude of cross-protection conferred by A(H3N2) preimmunity against three distinct zoonotic subtypes-A(H5N1), A(H7N9), and A(H9N2)-in the ferret model, we show that HA or NA relatedness to the priming A(H3N2) virus is not sufficient to predict cross-protection outcomes. Notably, A(H3N2) preimmunity provided some protection against clade 2.3.4.4b A(H5N1) virus infection despite sharing neither an HA within the same phylogenetic group nor an NA within the same subtype, whereas cross-protection against A(H7N9), which shares a group 2 HA, was limited. These findings underscore the need to evaluate both humoral and cell-mediated immunity against multiple viral antigens when assessing cross-protection elicited by seasonal influenza viruses.

Keywords: A(H3N2); A(H5N1); A(H7N9); A(H9N2); clade 2.3.4.4b; cross-protection; ferrets; influenza A virus; prior infection.

 
Back
Top